Teva
As of the edition of 20 October 2026, Teva runs 95 drugs, 58 of them marketed; it is on route A at 24 targets and on route B at 14 targets.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 17 company names in this family.
- NuPathe Inc.: acquired in 2014; successor BARR PHARMACEUTICALS
- Duramed Pharmaceuticals, Inc.: renamed in 2020
- BARR PHARMACEUTICALS: acquired
Drugs by status
| Status | Count |
|---|---|
| Marketed | 58 |
| Active | 8 |
| Went quiet | 12 |
| Stopped | 16 |
| Status not established | 1 |
| Total | 95 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Oxaliplatin | none listed | 0 |
| Cytarabine | none listed | 0 |
| Fentanyl | none listed | 6 |
| Fulvestrant | none listed | 1 |
| Azithromycin | none listed | 0 |
| Topotecan | none listed | 1 |
| Bendamustine | Ends 2029 (patent) | 0 |
| Risperidone | none listed | 2 |
| Naltrexone | none listed | 6 |
| Albuterol | none listed | 2 |
| Hydrochlorothiazide | none listed | 4 |
| Metronidazole | none listed | 0 |
| Testosterone | none listed | 4 |
| Fluticasone propionate | none listed | 2 |
| Furosemide | none listed | 2 |
| Levonorgestrel | none listed | 4 |
| Salmeterol | none listed | 1 |
| Arsenic trioxide | none listed | 1 |
| Modafinil | none listed | 2 |
| Ursodiol | none listed | 1 |
| Romidepsin | none listed | 0 |
| Fluticasone | none listed | 2 |
| Acetazolamide | none listed | 3 |
| Beclomethasone dipropionate | none listed | 3 |
| Desvenlafaxine | Ends 2027 (patent) | 0 |
A route B row is one company at one target. 33 more marketed drugs are not listed here.
Where it needs a new molecule
Route A at 24 targets, route B at 14 targets.
All 38 rows on route A or B
In the product38 company-target rows on route A or B; 35 are not shown here, and no score is.
See all 38 targets where Teva needs a new molecule, with the facts behind eachRequest access. Nothing is shown until you do.
Where its trials are
- Nervous system: 54 trials led
- Cancer: 38 trials led
- Immune system: 36 trials led